At Fox Chase Cancer Center, specialists consider PSA levels, biopsy results, imaging, risk group, overall health, and personal priorities when helping patients choose a course of care.
(WHTM) — A treatment option for prostate cancer patients is now available in the Midstate. The UPMC Hillman Cancer Center in Harrisburg can now provide HDR, or high-dose rate prostate brachytherapy.
We retrospectively analyzed 317 patients with LACC treated between 2014 and 2020. All patients received pelvic irradiation (46 Gy in 23 fractions) with once weekly cisplatin (40 mg/m 2), followed by ...